HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals

被引:356
作者
Mazzoli, S
Trabattoni, D
Caputo, SL
Piconi, S
Ble, C
Meacci, F
Ruzzante, S
Salvi, A
Semplici, F
Longhi, R
Fusi, ML
Tofani, N
Biasin, M
Villa, ML
Mazzotta, F
Clerici, M
机构
[1] UNIV MILAN, PADIGL LITA, CATTEDRA IMMUNOL, I-20157 MILAN, ITALY
[2] OSPED SM ANNUNZIATA, ASL 10, CTR MST UO MALATTIE INFETT, I-50100 FLORENCE, ITALY
[3] OSPED L SACCO, DIV MALATTIE INFETT 1, I-21057 MILAN, ITALY
[4] CNR, IST CHIM ORMONI, I-20131 MILAN, ITALY
关键词
D O I
10.1038/nm1197-1250
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-specific mucosal and cellular immunity was analyzed in heterosexual couples discordant for HIV status in serum and in HIV-unexposed controls. HIV-specific IgA but not IgG was present in urine and vaginal wash samples from HIV-exposed seronegative individuals (ESN), whereas both IgA and IgG were observed in their HIV-seropositive partners; antibodies were not detected in low-risk controls. Envelope protein (Env) peptide-stimulated interleukin-2 (IL-2) production by peripheral blood mononuclear cells (PBMCs) was detected in 9 out of 16 ESNs, 5 out of 16 HIV-infected patients and 1 out of 50 controls. Env peptide-stimulated PBMCs of ESNs produced more IL-2 and less IL-10 compared with those of HIV-infected individuals; no differences were observed in chemokine production or in CCR5 expression. These data demonstrate that a compartmentalized immune response to pathogens is possible in humans and raise the possibility of protective roles for cell-mediated immunity and mucosal IgA in HIV-seronegative individuals exposed to HIV.
引用
收藏
页码:1250 / 1257
页数:8
相关论文
共 54 条
[1]  
ALEXANDER NJ, 1990, FERTIL STERIL, V54, P1
[2]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[3]   HIV-1 ANTIBODY SERUM NEGATIVITY WITH VAGINAL SECRETIONS POSITIVITY [J].
BELEC, L ;
TEVIBENISSAN, C ;
GRESENGUET, G ;
MEILLET, D ;
PILLOT, J .
LANCET, 1994, 343 (8904) :1046-1047
[4]   NEUTRALIZATION OF HIV-1 BY SECRETORY IGA INDUCED BY ORAL IMMUNIZATION WITH A NEW MACROMOLECULAR MULTICOMPONENT PEPTIDE VACCINE CANDIDATE [J].
BUKAWA, H ;
SEKIGAWA, KI ;
HAMAJIMA, K ;
FUKUSHIMA, J ;
YAMADA, Y ;
KIYONO, H ;
OKUDA, K .
NATURE MEDICINE, 1995, 1 (07) :681-685
[5]   VACCINE PROTECTION OF RHESUS MACAQUES AGAINST SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
CARLSON, JR ;
MCGRAW, TP ;
KEDDIE, E ;
YEE, JL ;
ROSENTHAL, A ;
LANGLOIS, AJ ;
DICKOVER, R ;
DONOVAN, R ;
LUCIW, PA ;
JENNINGS, MB ;
GARDNER, MB .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) :1239-1246
[6]   HELPER T-CELL ANTIGENIC SITE IDENTIFICATION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME VIRUS GP120 ENVELOPE PROTEIN AND INDUCTION OF IMMUNITY IN MICE TO THE NATIVE PROTEIN USING A 16-RESIDUE SYNTHETIC PEPTIDE [J].
CEASE, KB ;
MARGALIT, H ;
CORNETTE, JL ;
PUTNEY, SD ;
ROBEY, WG ;
OUYANG, C ;
STREICHER, HZ ;
FISCHINGER, PJ ;
GALLO, RC ;
DELISI, C ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) :4249-4253
[7]   CYTOTOXIC LYMPHOCYTE-T RESPONSES IN THE PERIPHERAL-BLOOD OF CHILDREN BORN TO HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED MOTHERS [J].
CHEYNIER, R ;
LANGLADEDEMOYEN, P ;
MARESCOT, MR ;
BLANCHE, S ;
BLONDIN, G ;
WAINHOBSON, S ;
GRISCELLI, C ;
VILMER, E ;
PLATA, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (09) :2211-2217
[8]  
CLARICI M, 1994, JAMA-J AM MED ASSOC, V271, P42
[9]   CELL-MEDIATED IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN SERONEGATIVE HOMOSEXUAL MEN WITH RECENT SEXUAL EXPOSURE TO HIV-1 [J].
CLERICI, M ;
GIORGI, JV ;
CHOU, CC ;
GUDEMAN, VK ;
ZACK, JA ;
GUPTA, P ;
HO, HN ;
NISHANIAN, PG ;
BERZOFSKY, JA ;
SHEARER, GM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1012-1019
[10]   CELLULAR IMMUNE FACTORS ASSOCIATED WITH MOTHER-TO-INFANT TRANSMISSION OF HIV [J].
CLERICI, M ;
SISON, AV ;
BERZOFSKY, JA ;
RAKUSAN, TA ;
BRANDT, CD ;
ELLAURIE, M ;
VILLA, M ;
COLIE, C ;
VENZON, DJ ;
SEVER, JL ;
SHEARER, GM .
AIDS, 1993, 7 (11) :1427-1433